Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1829663Generated: October 25, 2026

1,4'-Bipiperidine → 6-[3,5-Bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-5-oxo-2-[4-(piperidine-1-yl)piperidine-1-yl]pyrimido[4,5-b][1,5]diazocine

https://huagongshe.com/reaction/1829663

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1,4'-BipiperidineHCID 78607—
Reactant6-[3,5-Bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-(methylsulfonyl)-5-oxopyrimido[4,5-b][1,5]diazocineHCID 22053591—
Product6-[3,5-Bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-5-oxo-2-[4-(piperidine-1-yl)piperidine-1-yl]pyrimido[4,5-b][1,5]diazocineHCID 2205359286%

Reaction Steps

In a similar manner to Example 1, 6-[3,5-bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-(methylsulfonyl)-5-oxopyrimido[4,5-b][1,5]diazocine (Compound of Reference Example 19; 85.9 mg) was reacted with 4-(piperidine-1-yl)piperidine (30.3 mg) to obtain 6-[3,5-bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-5-oxo-2-[4-(piperidine-1-yl)piperidine-1-yl]pyrimido[4,5-b][1,5]diazocine (85.3 mg, 86%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07064119B2
Source datasetuspto-grants-2006_06
ORD IDord-dab6e1de0e8246378cdf7c9d291e87c7
Source noteuspto-grants-2006_06